Stephanie Chan
About Stephanie Chan
Stephanie Chan is the Associate Director of Global Regulatory Strategy for Cardiovascular at Bristol Myers Squibb, with extensive experience in regulatory affairs and drug development across various therapeutic areas.
Current Title and Role at Bristol Myers Squibb
Stephanie Chan currently serves as the Associate Director, Global Regulatory Strategy, Cardiovascular at Bristol Myers Squibb. In this role, she leads regulatory strategy initiatives for cardiovascular therapies and serves as a key contact with the FDA for the mavacamten program targeting obstructive hypertrophic cardiomyopathy.
Previous Roles at Bristol Myers Squibb
Before her current role, Stephanie Chan was the Associate Director, Regulatory Strategy at Bristol Myers Squibb from 2020 to 2021. During this time, she was involved in formulating and executing regulatory strategies in various therapeutic areas, leveraging her extensive experience from previous positions.
Work Experience at MyoKardia
Stephanie Chan has held key positions at MyoKardia, including Associate Director, Regulatory Strategy in 2020 and Senior Manager, Regulatory Strategy from 2019 to 2020. Her work at MyoKardia involved key strategic regulatory responsibilities, aiding in the drug development process.
Career at Theravance Biopharma US, Inc.
Stephanie Chan held multiple roles at Theravance Biopharma US, Inc., starting as an Associate, Regulatory Affairs in 2013 and progressing to Manager and Senior Manager, Regulatory Affairs, until 2019. Her responsibilities included managing regulatory submissions and liaising with health authorities across various therapeutic areas.
Educational Background in Chemistry
Stephanie Chan holds a Bachelor's degree in Chemistry, magna cum laude, from Wellesley College. She also earned two Master of Science degrees in Chemistry from the University of California, Berkeley, and the University of Wisconsin-Madison. Additionally, she has a Certificate in Clinical Trials Design & Management from San Francisco State University.
Industry Experience in Medicinal Chemistry
Stephanie Chan has a robust background in medicinal chemistry, having worked as a Senior Research Associate at Genelabs Technologies for four years and as a Research Associate at Plexxikon Inc. Her expertise includes small molecule drug discovery and early and late-stage drug development.